Plus, Centene still facing Medicaid headwinds
 

Featured

Humana exiting Medicare Advantage in 13 markets

Humana is pulling back from Medicare Advantage markets and cutting benefits next year. The insurer expects it will lose thousands of members and supplemental benefit utilization will be high toward the end of this year.
 

Top Stories

Advocates rush to Congress, White House to extend telehealth prescribing for two years, after DEA's plans leaked

The Drug Enforcement Administration was expected to publish its proposed telehealth prescribing rule in September. A former official shared the agency's plans, which shattered the expectations of stakeholders.

Medicaid redeterminations still affecting Centene as stock plunges

Centene's stock sunk Wednesday after the company highlighted issues it faces surrounding Medicaid redeterminations.

Humana study: Senior-focused primary care can boost access, improve outcomes

Over the past several years, Humana has made significant strides in growing its senior-focused primary care business, and a new study highlights areas where it's seeing success in this model.

UnitedHealthcare, HCA Healthcare settle contract dispute, narrowly avoiding coverage interruption

“This means UnitedHealthcare plan members and their families will continue to have access to the convenient and quality healthcare they have come to expect from our care teams," HCA Healthcare said in a statement.

Elevance Health adds ACA plans in Florida, Maryland, Texas

Elevance Health subsidiary Wellpoint is debuting plans in three states for the 2025 coverage year.

SCAN embraces 'rebels with a cause' founding in new brand identity

SCAN Group is refreshing its visual identity, building its new look around honoring the "rebels with a cause" that founded the company and who continue to inspire its work.

8 Ascension hospitals joining Henry Ford Health joint venture on Sept. 30

The deal announced last year creates a 13-hospital, 50,000-person joint venture hospital system that retains Henry Ford Health's branding and headquarters.

Evernorth's Accredo to make Stelara biosimilar available at $0 out-of-pocket

Evernorth's Accredo specialty pharmacy will offer biosimilars for the popular immunotherapy Stelara at $0 for eligible patients, the company announced Thursday.

Healthcare Dealmakers—Jefferson Health, LVHN merge; R1 RCM going private and more

Steward Health Care bankruptcy updates, Allstate's $2 billion employer voluntary benefits arm sell-off and more merger and acquisition news from August.
 
Fierce podcasts

Don’t miss an episode

Minimizing plastics use and risk in healthcare 

In this week's episode of "Podnosis," two experts break down the history of plastics use in the healthcare sector and what it would take for an organization to phase them out.
 

Resources

Whitepaper

D’Andra D. Bingham, MD, Brings Fun Back into Clinic Days with NextGen Ambient Assist

“I think NextGen Ambient Assist will keep people practicing medicine for a lot longer. It makes it all so much simpler,” said Dr. D’Andra D. Bingham.
Whitepaper

The Health Equity Index: How Health Plans Can Get Ahead

Medicare Advantage plans: learn how to leverage data, personalize social risk factor screenings, and collaborate for better health outcomes in our white paper, The Health Equity Index: How Plans Can Get Ahead of the Curve.

 
 

Upcoming Fierce Events

9-12
Sep
Philadelphia, PA
11
Sep
Philadelphia, PA
17-19
Sep
Virtual Event
25-26
Sep
San Diego, CA
25-27
Sep
Philadelphia, PA

View all events